EGX
10.50 EGP
+20.00%More than 12 months
Buy stock at the current price
March 16, 2026 at 10:05:00 AM
Medium
85.00%
20.00%
Nozha International Hospital has demonstrated consistent revenue growth, with a 19.36% year-over-year increase in FY2024. The stock has appreciated by 31.55% over the past 52 weeks, indicating strong market performance. Additionally, the company maintains a robust net cash position, enhancing its financial stability. These factors position NINH for potential growth in the medium to long term.
The stock has shown a 31.55% increase over the last 52 weeks, with a year-to-date rise of 1.88%. Its 52-week range is EGP 5.95 to EGP 10.20, reflecting significant growth potential.
The Egyptian healthcare sector is expanding, driven by population growth and increased demand for quality medical services. Nozha International Hospital is well-positioned to capitalize on these trends.
Nozha International Hospital operates in a competitive healthcare market, offering a wide range of medical services. Its consistent financial performance and market appreciation suggest a strong competitive position.
Nozha International Hospital exhibits strong financial health, consistent revenue growth, and a solid market position. These factors, coupled with a positive outlook for the Egyptian healthcare sector, support a 'buy' recommendation with a target price of EGP 10.50, offering an estimated 20% return.
- Strong financial growth with a 19.36% revenue increase in FY2024.
- Stock appreciation of 31.55% over the past 52 weeks.
- Solid net cash position enhancing financial stability.
- Positive outlook for the Egyptian healthcare sector supporting future growth.
